{"id":"https://openalex.org/W2771175339","doi":"https://doi.org/10.5414/cn109281","title":"Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal function","display_name":"Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal function","publication_year":2017,"publication_date":"2017-12-12","ids":{"openalex":"https://openalex.org/W2771175339","doi":"https://doi.org/10.5414/cn109281","mag":"2771175339","pmid":"https://pubmed.ncbi.nlm.nih.gov/29231162"},"language":"en","primary_location":{"id":"doi:10.5414/cn109281","doi":"https://doi.org/10.5414/cn109281","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cn109281","pdf_url":null,"source":{"id":"https://openalex.org/S16687455","display_name":"Clinical Nephrology","issn_l":"0301-0430","issn":["0301-0430"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Matthew R. Weir","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew R. Weir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051784294","display_name":"Lloyd Peter Haskell","orcid":"https://orcid.org/0000-0002-2468-2523","observed_orcids":["https://orcid.org/0000-0002-2468-2523"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lloyd Haskell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088731576","display_name":"Jeffrey S. Berger","orcid":"https://orcid.org/0000-0001-8216-4647","observed_orcids":["https://orcid.org/0000-0001-8216-4647"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey S. Berger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076322910","display_name":"Veronica Ashton","orcid":"https://orcid.org/0000-0003-4880-1897","observed_orcids":["https://orcid.org/0000-0003-4880-1897"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Veronica Ashton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017834828","display_name":"Fran\u00e7ois Lalibert\u00e9","orcid":"https://orcid.org/0000-0003-2601-6214","observed_orcids":["https://orcid.org/0000-0003-2601-6214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Lalibert\u00e9","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087850384","display_name":"Concetta Crivera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Concetta Crivera","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034222724","display_name":"Kip Brown","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kip Brown","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105457474","display_name":"Patrick Lef\u00e8bvre","orcid":"https://orcid.org/0000-0002-2216-5442","observed_orcids":["https://orcid.org/0000-0002-2216-5442"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick Lefebvre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111566386","display_name":"Jeffrey R Schein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey Schein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4763,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.84366239,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"89","issue":"5","first_page":"314","last_page":"329"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-valvular-atrial-fibrillation","display_name":"non-valvular atrial fibrillation","score":0.9929999709129333},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":1.0},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":1.0},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.984000027179718},{"id":"https://openalex.org/keywords/estimated-creatinine-clearance","display_name":"estimated creatinine clearance","score":0.7559999823570251},{"id":"https://openalex.org/keywords/ischemic-stroke","display_name":"ischemic stroke","score":0.8489999771118164},{"id":"https://openalex.org/keywords/thromboembolic-events","display_name":"thromboembolic events","score":0.9700000286102295},{"id":"https://openalex.org/keywords/major-bleeding","display_name":"major bleeding","score":0.9769999980926514},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9010000228881836},{"id":"https://openalex.org/keywords/anticoagulation-outcomes","display_name":"anticoagulation outcomes","score":0.5730000138282776}],"concepts":[{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.9830138683319092},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9449464678764343},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.8491153717041016},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8298025727272034},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.7035341262817383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6606820225715637},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.6504299640655518},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4953259527683258},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4559690058231354},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.13657641410827637},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5414/cn109281","doi":"https://doi.org/10.5414/cn109281","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cn109281","pdf_url":null,"source":{"id":"https://openalex.org/S16687455","display_name":"Clinical Nephrology","issn_l":"0301-0430","issn":["0301-0430"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Nephrology","raw_type":"journal-article"},{"id":"pmid:29231162","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29231162","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical nephrology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6958903769","https://openalex.org/W2604914317","https://openalex.org/W2148984742","https://openalex.org/W2581510606","https://openalex.org/W2324744429","https://openalex.org/W2965407643","https://openalex.org/W3138291983","https://openalex.org/W2968377310","https://openalex.org/W2048896102","https://openalex.org/W2524154881"],"abstract_inverted_index":{"BACKGROUND:":[0],"Renal":[1],"dysfunction":[2,144,167,228,242],"increases":[3],"the":[4,38,137,197],"risk":[5],"of":[6,96,240,259],"thromboembolic":[7,56,171,211,248],"and":[8,65,83,106,111,123,128,164,180,188,255],"bleeding":[9,67,191],"events":[10,57,68],"in":[11],"patients":[12,23,72,224],"with":[13,24,49,113,130,142,163,202,225],"nonvalvular":[14],"atrial":[15],"fibrillation":[16],"(NVAF).":[17],"MATERIALS":[18],"AND":[19],"METHODS:":[20],"Adult":[21],"NVAF":[22,223],"\u2265":[25,204],"6":[26],"months":[27],"prior":[28],"to":[29,158,193,236,252],"first":[30],"warfarin":[31,108,125,159,194,253],"or":[32,62],"rivaroxaban":[33,105,122,140,161,200,244],"dispensing":[34],"were":[35,69,91,217],"selected":[36],"from":[37],"IMS":[39],"Health":[40],"Real-World":[41],"Data":[42],"Adjudicated":[43],"Claims":[44],"database":[45],"(05/2011":[46],"-":[47],"06/2015)":[48],"electronic":[50],"medical":[51],"records.":[52],"Ischemic":[53],"stroke":[54,149,233],"events,":[55],"(venous":[58],"thromboembolism,":[59],"myocardial":[60],"infarction,":[61],"ischemic":[63],"stroke),":[64],"major":[66,190,260],"compared":[70,157,235,251],"between":[71],"by":[73,77,266],"renal":[74,114,143,166,227,241],"function":[75],"identified":[76],"1)":[78],"relevant":[79],"ICD-9-CM":[80],"diagnosis":[81],"codes":[82],"2)":[84],"estimated":[85],"creatinine":[86],"clearance":[87],"(eCrCl).":[88],"Baseline":[89],"confounders":[90],"adjusted":[92],"using":[93],"inverse":[94],"probability":[95],"treatment":[97],"weights.":[98],"RESULTS:":[99],"The":[100,117],"diagnosis-based":[101,138],"analysis":[102,119,263],"included":[103,120],"39,872":[104],"48,637":[107],"users":[109,126,141,162,201,245],"(3,572":[110],"8,230":[112],"dysfunction,":[115],"respectively).":[116,135],"eCrCl-based":[118,198,262],"874":[121],"1,069":[124],"(66":[127],"208":[129],"eCrCl":[131,203],"<":[132,178,185],"60":[133,205],"mL/min,":[134],"In":[136,196],"analysis,":[139,199],"had":[145,168,207,229,246],"a":[146,208,230,256,267],"significantly":[147,169,209,231],"lower":[148,170,210,232,247],"rate":[150,234,258],"(HR":[151,174],"=":[152,155,175,182],"0.55,":[153],"p":[154,177,184],"0.0004)":[156],"users;":[160],"without":[165],"event":[172,212,249],"rates":[173,192,250],"0.62,":[176],"0.0001;":[179],"HR":[181],"0.64,":[183],"0.0001,":[186],"respectively),":[187],"similar":[189,257],"users.":[195],"mL/min":[206],"rate,":[213],"but":[214],"other":[215],"outcomes":[216],"not":[218],"statistically":[219],"significant.":[220],"CONCLUSION:":[221],"Rivaroxaban-treated":[222],"diagnosed":[226],"warfarin-treated":[237],"patients.":[238],"Regardless":[239],"diagnoses,":[243],"users,":[254],"bleeding.":[261],"was":[264],"limited":[265],"small":[268],"sample":[269],"size.":[270],".":[271]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-12-22T00:00:00"}